The contribution of cytotoxic and noncytotoxic function by donor T-cells that support engraftment after allogeneic bone marrow transplantation

Biology of Blood and Marrow Transplantation

Volumn 8, Issue 11, 2002, Pages 588-596

  Jiang, Zhe ^a   Adams, Gregor B ^b   Hanash, Alan M ^a   Scadden, David T ^b   Levy, Robert B ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Bone marrow transplantation; CD8+ T cell cytotoxicity; Engraftment; Facilitation

Indexed keywords

CARBOXYFLUORESCEIN DIACETATE SUCCINIMIDYL ESTER; CD45 ANTIGEN; CD8 ANTIGEN; COBALT 60; FAS LIGAND; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PERFORIN;

ALLOGENIC BONE MARROW TRANSPLANTATION; ANIMAL CELL; B LYMPHOCYTE; CELL ACTIVATION; CELL ACTIVITY; CELL FRACTIONATION; CELL POPULATION; CHIMERA; COLONY FORMING UNIT GM; CONTROLLED STUDY; CYTOTOXICITY; DONOR; EFFECTOR CELL; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC SYSTEM; ISOGRAFT; LYMPHOCYTE DEPLETION; LYMPHOCYTE FUNCTION; LYMPHOCYTE HOMING; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; MOUSE STRAIN; NONHUMAN; PROTEIN FUNCTION; RECIPIENT; REVIEW; SPLEEN; STEM CELL; T LYMPHOCYTE; WHOLE BODY RADIATION; WILD TYPE;

EID: 6444245092     PISSN: 10838791     EISSN: None     Source Type: Journal    
DOI: 10.1053/bbmt.2002.v8.abbmt080588     Document Type: Article

References (42)

1. Nickerson P, Zheng XX, Steiger J, et al. Prolonged islet allograft acceptance in the absence of interleukin 4 expression. Transpl Immunol. 1996;4:81-85.
2. Martin PJ, Hansen JA, Storb R, et al. Human marrow transplantation: an immunological perspective. Adv Immunol. 1987;40: 379-438.
3. Emerson SG, Gale RP. The regulation of hematopoiesis following bone marrow transplantation. Int J Cell Cloning. 1987;5:432-449.
4. Chen W, Wu X, Levasseur DN, et al. Lentiviral vector transduction of hematopoietic stem cells that mediate long-term reconstitution of lethally irradiated mice. Stem Cells. 2000;18:352-359.
5. Rambaldi A, Borleri G, Dotti G, et al. Innovative two-step negative selection of granulocyte colony-stimulating factor-mobilized circulating progenitor cells: adequacy for autologous and allogeneic transplantation. Blood. 1998;91:2189-2196.
6. Fibbe WE, Mark J, Zijlmans JM, et al. Stem cells with short-term and long-term repopulating ability in the mouse. Ann Oncol. 1996;7:15-18.
7. Zijlmans JM, Visser JW, Laterveer L, et al. The early phase of engraftment after murine blood cell transplantation is mediated by hematopoietic stem cells. Proc Natl Acad Sci USA. 1998;95:725-729.
8. Nibley WE, Spangrude GJ. Primitive stem cells alone mediate rapid marrow recovery and multilineage engraftment after transplantation. Bone Marrow Transplant. 1998;21:345-354.
9. Jiang Z, Podack ER, Levy RB. Donor T cells which cannot mediate perforin-dependent and FasL-dependent cytotoxicity can effect graft vs. host reactivity following allogeneic bone marrow transplantation. Period Biol. 1998;100:477-481.
10. Jiang Z, Podack E, Levy RB. Major histocompatibility complex-mismatched allogeneic bone marrow transplantation using perforin and/or Fas ligand double-defective CD4(+) donor T cells: involvement of cytotoxic function by donor lymphocytes prior to graft-versus-host disease pathogenesis. Blood. 2001;98:390-397.
11. Jones M, Komatsu M, Levy RB. Cytotoxically impaired transplant recipients can efficiently resist major histocompatibility complex-matched bone marrow allografts. Biol Blood Marrow Transplant. 2000;6:456-464.
12. Martin PJ, Akatsuka Y, Hahne M, et al. Involvement of donor T cell cytotoxic effector mechanisms in preventing allogeneic marrow graft refection. Blood. 1998;92:2177-2181.
13. Martin PJ. Donor CD8 cells prevent allogeneic marrow graft rejection in mice: potential implications for marrow transplantation in humans. J Exp Med. 1993;178:703-712.
14. Bennett M. Rejection of marrow grafts. Importance of H-2 homozygosity of donor cells. Transplantation. 1972;14:289-298.
15. Murphy WJ, Kumar V, Bennett M. Acute rejection of murine bone marrow allografts by natural killer cells and T cells: differences in kinetics and target antigens recognized. J Exp Med. 1987;166:1499-1509.
16. Yankelevich B, Knobloch C, Nowicki M, et al. A novel cell type responsible for marrow graft rejection in mice: T cells with NK phenotype cause acute rejection of marrow grafts. J Immunol. 1989;142:3423-3430.
17. Yu YYL, Kumar V, Bennett M. Murine natural killer cells and marrow graft rejection. Ann Rev Immunol. 1992;10:189-213.
18. Quinones RR. Hematopoietic engraftment and graft failure after bone marrow transplantation. Am J Pediatr Hematol Oncol. 1993; 15:3-17.
19. Takeda Y, Moore MW, Dennert G. Acute rejection of marrow grafts in mice: dependence on and independence of functional TcR in the rejection process. J Immunol. 1994;152:4402-4416.
20. Vallera DA, Taylor PA, Sprent J, et al. The role of host T cell subsets in bone marrow rejection directed to isolated major histocompatibility complex class I versus class II differences of bm1 and bm12 mutant mice. Transplantation. 1994;57:249-256.
21. Lee LA, Sergio JJ, Sykes M. Natural killer cells weakly resist engraftment of allogeneic, long-term, multilineage-repopulating hematopoietic stem cells. Transplantation. 1996;61:125-132.
22. Burnett AK, Hann IM, Robertson AG. Prevention of graft-versus-host disease by ex vivo T cell depletion: reduction in graft failure with augmented total body irradiation. Leukemia. 1988;2:300-303.
23. Patterson J, Prentice HG, Brenner MY, et al. Graft rejection following HLA matched T-lymphocyte depleted bone marrow transplantation. Br J Haematol. 1986;63:221-230.
24. Kernan NA, Bordignon C, Heller G, et al. Graft failure after T-cell depleted human leukocyte antigen identical marrow transplants for leukemia; I, analysis of risk factors and results of secondary transplants. Blood. 1989;74:2227-2236.
25. Delain M, Cahn JY, Racadot E. Graft failure after T cell depleted HLA identical allogeneic bone marrow transplantation: risk factors in leukemic patients. Leuk Lymphoma. 1993;11:359-368.
26. Przepiorka D, Huh YO, Khouri I, et al. Graft failure and graft-vs-host disease after subtotal T-cell-depleted marrow transplantation: correlations with marrow hematopoietic and lymphoid subsets. Prog Clin Biol Res. 1994;389:557-563.
27. Martin PJ. The role of donor lymphoid cells in allogeneic marrow engraftment. Bone Marrow Transplant. 1990;6:283-289.
28. Murphy WJ, Bennett M, Kumar V, et al. Donor-type activated natural killer cells promote marrow engraftment and B cell development during allogeneic bone marrow transplantation. J Immunol. 1992;148:2953-2960.
29. Drobyski WR, Majewski D. Donor gamma delta T lymphocytes promote allogeneic engraftment across the major histocompatibility barrier in mice. Blood. 1997;89:1100-1109.
30. Kawanishi Y, Passweg J, Drobyski WR, et al. Effect of T cell subset dose on outcome of T cell-depleted bone marrow transplantation. Bone Marrow Transplant. 1997;19:1069-1077.
31. Yaroslavskiy B, Colson Y, Ildstad S, et al. Addition of bone marrow "facilitating cell" populations increases stem cell-derived cobblestone area formation in impaired long term bone marrow culture stroma. Exp Hematol. 1998;26:604-611.
32. -cells in whole bone marrow facilitate the engraftment of hematopoietic stem cells across allogeneic barriers. Immunity. 1999;11: 579-590.
33. Fibbe WE, Zijlmans JM, Willemze R. Differential short-term and long-term repopulating ability of stem cell subsets in mice. Stem Cells. 1997;15(suppl 1):47-51.
34. Adams GB, Chabner KT, Foxall RB, et al. Heterologous cells cooperate to augment stem cell migration, homing and engraftment. Blood. In press.
35. Zamai L, Secchiero P, Pierpaoli S, et al. TNF-related apoptosis-inducing ligand (TRAIL) as a negative regulator of normal human erythropoiesis. Blood. 2000;95:989-996.
36. Rusten LS, Jacobsen SJ. Tumor necrosis factor (TNF)-alpha directly inhibits human erythropoiesis in vitro: role of p55 and p75 TNF receptors. Blood. 1995;85:989-996.
37. Wiesmann A, Kim M, Georgelas A, et al. Modulation of hematopoietic stem/progenitor cell engraftment by transforming growth factor beta. Exp Hematol. 2000;28:128-139.
38. Martin PJ. Prevention of allogeneic marrow graft rejection by donor T cells that do not recognize recipient alloantigens: potential role of a veto mechanism. Blood. 1996;88:962-969.
39. Davenport C, George T, Devora GA, et al. Facilitation of parental-strain marrow engraftment by T cells of neonatally-tolerant mice. Biol Blood Marrow Transplant. 1997;3:294-303.
40. Vallera D, Taylor PA, Widmer MB, et al. Interleukin-1 alpha-mediated promotion of long-term alloengraftment and short-term neutrophil expansion does not require the presence of either donor or host T cells. Transplantation. 1996;62:636-642.
41. Holyoake TL, Freshney MG, McNair L, et al. Ex vivo expansion with stem cell factor and interleukin-11 augments both short-term recovery posttransplant and the ability to serially transplant marrow. Blood. 1996;87:4589-4595.
42. Sitnicka E, Ruscetti FW, Priestley GV. Transforming growth factor beta 1 directly and reversibly inhibits the initial cell divisions of long-term repopulating hematopoietic stem cells. Blood. 1996;88:82-88.